For research use only
| Cat No. | ABC-RC009Y |
| Product Type | Reporter Stable Cell Lines |
| Cell Type | Epithelial |
| Species | Mouse |
| Host Cell | KLN205 |
| Source Organ | Lung |
| Disease | Squamous Cell Carcinoma |
| Storage | Liquid Nitrogen |
KLN205/STAT3 Reporter (Luc) Stable Cell Line by AcceGen provides quantitative bioluminescent monitoring of STAT3 pathway activation in cancer research.
KLN205/STAT3 Reporter (Luc) Stable Cell Line is a bioluminescent reporter model derived from murine lung squamous carcinoma KLN205 cells, featuring stable integration of a luciferase gene under STAT3-responsive promoter elements. This engineered system enables quantitative, real-time monitoring of STAT3 signaling activity through luciferase expression while maintaining the epithelial morphology and malignant characteristics of parental KLN205 cells. The reporter provides a powerful platform for investigating IL-6/JAK/STAT3 signaling in response to cytokines such as IL-6, EGF, and OSM or pharmacological inhibitors. Applications include high-throughput drug screening, evaluation of STAT3 in epithelial-mesenchymal transition (EMT), tumor–microenvironment crosstalk, and preclinical testing of JAK/STAT3 inhibitors. All cells are rigorously tested and confirmed negative for mycoplasma, fungi, yeast, and bacteria.
| Species | Mouse |
| Cat.No | ABC-RC009Y |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Lung |
| Disease | Squamous Cell Carcinoma |
| Biosafety Level | 2 |
| Storage | Liquid Nitrogen |
| Product Type | Reporter Stable Cell Lines |
| Host Cell | KLN205 |
| Gene Info | Luciferase (STAT3-responsive reporter) |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
The KLN205/STAT3 Reporter (Luc) Stable Cell Line enables real-time bioluminescent monitoring of STAT3 pathway activity in lung carcinoma research. It provides a sensitive tool for studying IL-6/JAK/STAT3 signaling, cancer immune evasion, EMT, and drug resistance. This cell line is particularly suited for high-throughput screening of STAT3-targeting therapeutics and mechanistic studies of tumor–microenvironment interactions.